Otipax, ear drops 15 ml/16 g
Manufacturer: Biocodex, France
$31.00
| Active ingredient: | |
|---|---|
| Dosage form: | |
| Indications for use: |
Indications
Indications
Local symptomatic treatment and analgesia in children from birth and adults with:
* otitis media in the acute period at the time of inflammation;
· otitis media as a complication after the flu·
* barotraumatic edema.
Dosage
How to take, course of administration and dosage
Otipax is applied topically, by instilling 3-4 drops into the external ear canal 2-3 times a day. To avoid contact of the cold solution with the auricle, the bottle should be warmed in the palms of your hands before use.
The duration of use of Otipax® is not more than 10 days, after which the prescribed treatment should be reviewed.
After the first opening of the bottle, the drug should be used for 6 months. Do not use after the expiration date indicated on the package.
Contraindications
Contraindications
- Hypersensitivity to the components of the drug;
- Perforation of the eardrum.
With caution:
It is necessary to ensure the integrity of the eardrum before starting the drug.
If the drug is used for a perforated eardrum, the drug may come into contact with the organs of the middle ear and lead to complications.
Information for athletes: the drug contains an active component that can give a positive reaction during doping control.
Composition
Composition
of 1 g of the solution contains:
Active ingredients:
lidocaine hydrochloride 10 mg,
phenazone 40 mg.
Auxiliary substances:
sodium thiosulfate 1 mg,
ethanol 221.8 mg,
glycerol 709 mg,
water 18.2 mg.
Composition
>
of 1 g of the solution contains:
Active ingredients:
lidocaine hydrochloride 10 mg,
phenazone 40 mg.
Auxiliary substances:
sodium thiosulfate 1 mg,
ethanol 221.8 mg,
glycerol 709 mg,
water 18.2 mg
. Pharmacological action
Local anti-inflammatory, analgesic antiseptic.
Phenazone has an anti-inflammatory and analgesic effect.
Lidocaine has a local anesthetic effect.
The drug does not enter the body with an intact eardrum.
Indications
Local symptomatic treatment and analgesia in children from birth and adults with:
* otitis media in the acute period at the time of inflammation;
· otitis media as a complication after the flu·
* barotraumatic edema.
Use during pregnancy and lactation
It is possible to use the drug Otipax during pregnancy and lactation according to indications, provided that the tympanic membrane is intact.
Contraindications
- Hypersensitivity to the components of the drug;
- Perforation of the eardrum.
With caution:It is necessary to ensure the integrity of the eardrum before starting the drug. If the drug is used for a perforated eardrum, the drug may come into contact with the organs of the middle ear and lead to complications. Information for athletes: the drug contains an active component that can give a positive reaction during doping control.
Side effects
There is a risk of allergic reactions, irritation and hyperemia of the ear canal.
Interaction
There are no data on the interaction of the drug with other drugs.
How to take, course of administration and dosage
Otipax is applied topically, by instilling 3-4 drops into the external ear canal 2-3 times a day. To avoid contact of the cold solution with the auricle, the bottle should be warmed in the palms of your hands before use.
The duration of use of Otipax® is not more than 10 days, after which the prescribed treatment should be reviewed.
After the first opening of the bottle, the drug should be used for 6 months. Do not use after the expiration date indicated on the package.
Overdose
Data on overdose of the drug Otipax are not provided.
Form of production
Otipax. Ear drops.
Storage conditions
Store at a temperature not exceeding 30 C.
Keep out of reach of children.
Shelf
life is 5 years, after opening the bottle-6 months.
Active ingredient
Lidocaine, Phenazone
Dosage form
of ear drops
Weight
Weight: 54 gr.
Best price for Otipax, ear drops 15 ml/16 g in our online pharmacy!
Side effects of Otipax, ear drops 15 ml/16 g.
Related products
Reviews
There are no reviews yet.